Liver function may change how KP-001 works in the body
NCT ID NCT06619054
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study looked at how different levels of liver damage affect the way the body handles a single dose of the experimental drug KP-001. Twenty-four adults with either healthy livers or mild to moderate liver problems took part. Researchers measured drug levels in the blood to see if liver impairment changes how the drug is processed or causes more side effects. The goal is to help doctors decide on safe dosing for people with liver issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sites contracted by Parexel
San Antonio, Texas, 08103, United States
Conditions
Explore the condition pages connected to this study.